Reinsurance
Octaviant Financial Announces Strategic Initiative with Starr Insurance
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Octaviant Financial's collaboration with
Starr Insurance enhances its drug warranty platform by providing pharmaceutical companies a dedicated carrier to underwrite and distribute their drug warranties. - With the inclusion of an insurance carrier that understands the complex regulatory requirements to issue these instruments, pharmaceutical companies will be able to offer valuable drug assurance programs that will resonate with payers, reduce the risks associated with failure, and differentiate pharmaceutical products in the market.
- Octaviant Financial also announced the formation of
Actuaria Insurance Services LLC , a licensed insurance agency wholly owned by Octaviant Financial specializing in drug assurance program administration services to pharmaceutical and insurance companies.
Click image above to view full announcement.
About Octaviant Financial
Octaviant Financial offers innovative financial, warranty and reinsurance solutions designed to help drug makers, payers and patients manage the cost of gene, cell and specialty therapies. Octaviant’s mission is to facilitate the adoption of transformational therapies by removing significant barriers for payers and patients seeking access. Our core strength is to leverage our combined experiences in the life sciences, finance, insurance, and reinsurance industries to meet our mission. Octaviant’s culture – to be innovative, collaborative, and client-centric – has allowed the firm to develop cutting edge ideas to fuel its proprietary instruments and services offerings. We provide full-service advice to our clients and assist them to think strategically through the most complex challenges facing drug delivery and reimbursement. In doing so, it is our hope that a healthcare system evolves to bring about more cures for patients living with disease. For more information, visit www.octaviantfx.com or follow us on LinkedIn.
Octaviant Financial offers innovative financial, warranty and reinsurance solutions designed to help drug makers, payers and patients manage the cost of gene, cell and specialty therapies. Octaviant’s mission is to facilitate the adoption of transformational therapies by removing significant barriers for payers and patients seeking access. Our core strength is to leverage our combined experiences in the life sciences, finance, insurance, and reinsurance industries to meet our mission. Octaviant’s culture – to be innovative, collaborative, and client-centric – has allowed the firm to develop cutting edge ideas to fuel its proprietary instruments and services offerings. We provide full-service advice to our clients and assist them to think strategically through the most complex challenges facing drug delivery and reimbursement. In doing so, it is our hope that a healthcare system evolves to bring about more cures for patients living with disease. For more information, visit www.octaviantfx.com or follow us on LinkedIn.
About Starr Insurance
Starr Insurance (or Starr) is a marketing name for the operating insurance and travel assistance companies and subsidiaries of Starr International Company, Inc. and for the investment business of C. V. Starr & Co., Inc. and its subsidiaries. Starr is a leading insurance and investment organization with a presence on six continents; through its operating insurance companies, Starr provides property, casualty, and accident and health insurance products as well as a range of specialty coverages including aviation, marine, energy and excess casualty insurance. Starr’s insurance company subsidiaries domiciled in the U.S. , Bermuda , China , Hong Kong , Malta , Singapore , Switzerland and U.K. each have an A.M. Best rating of “A” (Excellent). Starr’s Lloyd’s syndicate has a Standard & Poor’s rating of “A+” (Strong).
About Marsh
Marsh is the world’s leading insurance broker and risk advisor. With more than 45,000 colleagues advising clients in over 130 countries, Marsh serves commercial and individual clients with data-driven risk solutions and advisory services. Marsh is a business of Marsh McLennan (NYSE: MMC), the world’s leading professional services firm in the areas of risk, strategy and people. With annual revenue of $23 billion , Marsh McLennan helps clients navigate an increasingly dynamic and complex environment through four market-leading businesses: Marsh, Guy Carpenter , Mercer and Oliver Wyman . For more information, visit marsh.com, and follow us on LinkedIn and X.
Contacts:
[email protected]
Source: octaviantFinancial, Inc.
Distributed by:
- Octaviant Financial's collaboration with
Starr Insurance enhances its drug warranty platform by providing pharmaceutical companies a dedicated carrier to underwrite and distribute their drug warranties. - With the inclusion of an insurance carrier that understands the complex regulatory requirements to issue these instruments, pharmaceutical companies will be able to offer valuable drug assurance programs that will resonate with payers, reduce the risks associated with failure, and differentiate pharmaceutical products in the market.
- Octaviant Financial also announced the formation of
Actuaria Insurance Services LLC , a licensed insurance agency wholly owned by Octaviant Financial specializing in drug assurance program administration services to pharmaceutical and insurance companies.
Porch Group to Host Investor Day on December 5, 2024
AvevoRx Appoints Cary Goodin as Vice President of Managed Care
Advisor News
- Advisors must lead the policy risk conversation
- Gen X more anxious than baby boomers about retirement
- Taxing trend: How the OBBBA is breaking the standard deduction reliance
- Why advisors can’t afford to delay succession planning
- 6 in 10 Americans struggle with financial decisions
More Advisor NewsAnnuity News
- CT commissioner: 70% of policyholders covered in PHL liquidation plan
- ‘I get confused:’ Regulators ponder increasing illustration complexities
- Three ways the Corebridge/Equitable merger could shake up the annuity market
- Corebridge, Equitable merge to create potential new annuity sales king
- LIMRA: Final retail annuity sales total $464.1 billion in 2025
More Annuity NewsHealth/Employee Benefits News
- El Rio taps experienced leader to oversee transition from North Country HealthCare to Elk Ridge
- Many drop Obamacare and more likely will, SCC hears
- Legislature advances bill limiting copays for Medicaid recipients
- Legislature advances bill limiting copays for Medicaid recipients
- BREAKING: MIKE ROGERS' HEALTH CARE PLAN INCLUDES NEW OUT-OF-POCKET COSTS AND HIGH-RISKS POOLS THAT INCREASE PREMIUMS
More Health/Employee Benefits NewsLife Insurance News
- WHAT THEY ARE SAYING: KATHLEEN COULOMBE JOINS ACU AS CHIEF ADVOCACY OFFICER
- A-CAP Appoints Kirk Cullimore as President of Sentinel Security Life
- Nationwide enters centennial year stronger than ever
- AM Best Affirms Credit Ratings of Mutual of Omaha Insurance Company and Its Subsidiaries
- AM Best Affirms Credit Ratings of CMB Wing Lung Insurance Company Limited
More Life Insurance News